KROS Keros Therapeutics, Inc.

Fundamentals / CIK 0001664710 / USD

Keros Therapeutics, Inc. reported $40.42M in revenue and a net loss of $61.73M for the trailing twelve months ended September 30, 2026 (up 183.3% year over year), with a -181.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KROS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$260.1M$130.1M$0-$195.9MFY 2019 Revenue: $10.00MFY 2019 Net Income: -$12.34M2019FY 2020 Revenue: $0FY 2020 Net Income: -$45.36M2020FY 2021 Revenue: $20.10MFY 2021 Net Income: -$58.74M2021FY 2022 Revenue: $0FY 2022 Net Income: -$104.7M2022FY 2023 Revenue: $151KFY 2023 Net Income: -$153.0M2023FY 2024 Revenue: $0FY 2024 Net Income: -$187.4M2024FY 2025 Revenue: $243.9MFY 2025 Net Income: $87.01M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $243.9M $0 $151K $0 $20.10M $0 $10.00M
Research & Development $129.6M $173.6M $135.3M $87.27M $55.14M $33.86M $17.38M
Total Operating Expenses $176.5M $214.4M $170.1M $114.8M $76.47M $46.66M $20.56M
Operating Income $67.57M -$210.8M -$169.9M -$114.8M -$56.37M -$46.66M -$10.56M
EBITDA $69.08M -$209.6M -$169.1M -$114.1M -$55.99M -$46.38M -$10.36M
Interest Expense -- $0 $0 $1.0K $4.0K $6.0K --
Income Before Tax $91.90M -$187.1M -$153.0M -$104.7M -$56.73M -$45.53M -$12.34M
Income Tax Expense $4.88M $300K $0 $0 $2.01M -$172K $0
Net Income $87.01M -$187.4M -$153.0M -$104.7M -$58.74M -$45.36M -$12.34M
Basic EPS $2.34 -$5.00 -$5.20 -$4.15 -$2.52 -$2.93 -$6.08
Diluted EPS $2.30 -$5.00 -$5.20 -$4.15 -$2.52 -$2.93 -$6.08
Basic Shares Outstanding 37.2M 37.4M 29.4M 25.2M 23.3M 15.5M 2.3M
Diluted Shares Outstanding 37.9M 37.4M 29.4M 25.2M 23.3M 15.5M 2.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $40.01M $0 $32K $380K $14.12M $18.17M $211.2M $0
Research & Development $20.49M $22.33M $16.10M $17.91M $19.52M $43.50M $48.71M $45.63M
Total Operating Expenses $27.19M $30.94M $26.24M $29.66M $29.65M $57.98M $59.21M $56.30M
Operating Income $12.82M -$30.94M -$25.88M -$29.27M -$15.38M -$39.82M $152.0M -$53.25M
EBITDA $13.20M -$30.54M -$25.47M -$28.87M -$14.99M -$39.45M $152.4M -$52.92M
Interest Income $55K -- -- -- $0 -- -- --
Income Before Tax $14.93M -$28.71M -$23.71M -$24.98M -$8.70M -$32.92M $158.5M -$45.73M
Income Tax Expense $772K $0 $0 -$1.51M -$1.42M -$2.22M $10.04M $300K
Net Income $14.15M -$28.71M -$23.71M -$23.46M -$7.28M -$30.70M $148.5M -$46.03M
Basic EPS $0.71 -$1.45 -$1.21 -- -$0.18 -$0.76 $3.66 --
Diluted EPS $0.70 -$1.45 -$1.21 -- -$0.18 -$0.76 $3.62 --
Basic Shares Outstanding 19.9M 19.8M 19.6M -- 40.6M 40.6M 40.6M --
Diluted Shares Outstanding 20.3M 19.8M 19.6M -- 40.6M 40.6M 41.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $287.4M $559.9M $331.1M $279.0M $230.0M $265.9M $7.02M
Cash & Short-Term Investments $287.4M $559.9M $331.1M $279.0M $230.0M $265.9M $7.02M
Accounts Receivable, Net $3.57M $2.74M $143K $0 $18.00M $0 --
Other Current Assets $2.40M $1.45M $1.00M $276K $210K $160K $215K
Total Current Assets $315.4M $588.9M $347.3M $285.8M $251.4M $267.7M $8.93M
Property, Plant & Equipment, Net $4.30M $4.24M $4.13M $2.02M $1.33M $724K $708K
Other Non-Current Assets $0 $2.06M $2.05M $2.12M $82K $0 --
Total Non-Current Assets $22.59M $26.99M $22.73M $21.01M $3.81M $1.72M $2.03M
Total Assets $338.0M $615.9M $370.0M $306.8M $255.3M $269.4M $10.96M
Accounts Payable $1.97M $4.60M $5.45M $3.34M $3.65M $2.15M $2.09M
Deferred Revenue (Current) -- $0 -- -- -- -- --
Other Current Liabilities $217K $416K $665K $750K $204K $218K $269K
Total Current Liabilities $20.41M $27.45M $24.37M $16.55M $11.85M $7.18M $4.49M
Other Non-Current Liabilities -- -- -- -- $0 $62K $119K
Total Non-Current Liabilities $14.47M $16.88M $13.44M $12.81M $231K $538K $5.97M
Total Liabilities $34.89M $44.33M $37.81M $29.36M $12.08M $7.72M $10.46M
Total Debt (incl. Leases) $16.88M $18.86M $14.44M $13.27M $1.09M $899K $1.27M
Common Stock $4.0K $4.0K $3.0K $2.0K $2.0K $2.0K $1.0K
Retained Earnings -$481.8M -$568.8M -$381.4M -$228.4M -$123.8M -$65.01M -$19.65M
Total Stockholders' Equity $303.1M $571.6M $332.2M $277.4M $243.2M $261.7M -$19.45M
Total Equity $303.1M $571.6M $332.2M $277.4M $243.2M $261.7M -$19.45M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $259.5M $257.6M $281.5M $287.4M $693.5M $690.2M $720.5M $559.9M
Cash & Short-Term Investments $259.5M $257.6M $281.5M $287.4M $693.5M $690.2M $720.5M $559.9M
Accounts Receivable, Net $20.00M $0 $400K $3.57M $3.49M $15.82M $17.29M $2.74M
Other Current Assets $588K $760K $1.03M $2.40M $2.65M $2.52M $2.94M $1.45M
Total Current Assets $287.6M $266.9M $290.7M $315.4M $719.3M $732.8M $759.5M $588.9M
Property, Plant & Equipment, Net $3.39M $3.71M $3.96M $4.30M $4.56M $4.84M $4.47M $4.24M
Other Non-Current Assets $11K -- -- $0 $0 $0 $463K $2.06M
Total Non-Current Assets $19.74M $20.72M $21.62M $22.59M $23.48M $24.36M $25.05M $26.99M
Total Assets $307.4M $287.6M $312.3M $338.0M $742.8M $757.2M $784.6M $615.9M
Accounts Payable $3.79M $1.82M $1.49M $1.97M $2.30M $5.27M $6.64M $4.60M
Deferred Revenue (Current) -- -- -- -- $155K $925K $3.31M $0
Other Current Liabilities $316K $482K $88K $217K $212K $349K $532K $416K
Total Current Liabilities $15.86M $12.15M $12.85M $20.41M $24.09M $34.71M $39.38M $27.45M
Total Non-Current Liabilities $12.41M $13.13M $13.81M $14.47M $15.11M $15.72M $16.31M $16.88M
Total Liabilities $28.27M $25.28M $26.66M $34.89M $39.20M $50.43M $55.69M $44.33M
Total Debt (incl. Leases) $15.11M $15.72M $16.31M $16.88M $17.43M $17.95M $18.41M $18.86M
Common Stock $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K
Retained Earnings -$520.0M -$534.2M -$505.5M -$481.8M -$458.3M -$451.0M -$420.3M -$568.8M
Total Stockholders' Equity $279.1M $262.3M $285.6M $303.1M $703.6M $706.7M $728.9M $571.6M
Total Equity $279.1M $262.3M $285.6M $303.1M $703.6M $706.7M $728.9M $571.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $87.01M -$187.4M -$153.0M -$104.7M -$58.74M -$45.36M -$12.34M
Depreciation & Amortization $1.51M $1.23M $815K $674K $378K $278K $208K
Stock-Based Compensation $28.70M $34.87M $28.76M $18.68M $11.72M $4.10M $59K
Change in Receivables -$825K -$2.60M -$143K $18.00M -$18.00M $0 --
Change in Payables -$3.00M -$249K $1.61M -$408K $1.49M $61K $1.31M
Operating Cash Flow $107.5M -$160.9M -$124.5M -$70.06M -$62.15M -$36.89M -$16.00M
Capital Expenditure -$1.55M -$1.93M -$2.46M -$1.24M -$1.02M -$294K -$271K
Free Cash Flow $106.0M -$162.8M -$127.0M -$71.30M -$63.17M -$37.19M -$16.27M
Investing Cash Flow -$1.55M -$1.93M -$2.46M -$1.24M -$1.02M -$294K -$271K
Common Stock Issued -- -- -- -- -- $140.5M $0
Share Repurchases -$375.0M $0 -- -- -- -- --
Financing Cash Flow -$378.5M $391.8M $179.0M $120.3M $28.55M $296.0M $14K
Net Change in Cash -$272.5M $229.0M $51.98M $49.01M -$34.62M $258.9M -$16.25M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $14.15M -$28.71M -$23.71M -$23.46M -$7.28M -$30.70M $148.5M -$46.03M
Depreciation & Amortization $384K $402K $403K $400K $395K $370K $344K $332K
Stock-Based Compensation $4.20M $5.38M $6.20M $7.30M $3.99M $8.54M $8.86M $9.20M
Change in Receivables -$20.00M $400K $3.17M -$75K $12.32M $1.48M -$14.55M -$2.35M
Change in Payables $1.97M $323K -$108K -$697K -$2.96M -$1.37M $2.02M -$293K
Operating Cash Flow $3.39M -$20.42M -$3.53M -$27.29M $3.25M -$29.62M $161.2M -$46.01M
Capital Expenditure -$59K -$155K -$73K -$134K -$132K -$720K -$565K -$289K
Free Cash Flow $3.33M -$20.58M -$3.60M -$27.43M $3.12M -$30.34M $160.6M -$46.30M
Investing Cash Flow -$59K -$155K -$73K -$134K -$132K -$720K -$565K -$289K
Financing Cash Flow -$1.47M -$3.31M -$2.32M -$378.6M $140K $17K $4.0K $75.54M
Net Change in Cash $1.86M -$23.89M -$5.92M -$406.1M $3.26M -$30.33M $160.6M $29.25M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 27.7% -- -112543.7% -- -280.5% -- -105.6%
Net Profit Margin 35.7% -- -101319.2% -- -292.3% -- -123.4%
Return on Equity (ROE) 28.7% -32.8% -46.1% -37.7% -24.2% -17.3% --
Return on Assets (ROA) 25.7% -30.4% -41.3% -34.1% -23.0% -16.8% -112.6%
Current Ratio 15.45x 21.45x 14.25x 17.27x 21.23x 37.27x 1.99x
Quick Ratio 14.25x 20.50x 13.59x 16.86x 20.94x 37.01x 1.56x
Debt to Equity 0.06x 0.03x 0.04x 0.05x 0.00x 0.00x --
Revenue Growth (YoY) -- -100.0% -- -100.0% -- -100.0% --
5Y Revenue / Share Growth -- -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -181.3% -698.0% -337.4% 27.7% 17.9% 0.1% -4.9% --
Net Profit Margin -152.7% -572.1% -260.4% 35.7% 26.5% 8.2% 2.0% --
Return on Equity (ROE) -22.1% -31.7% -29.8% 28.7% 9.2% 2.7% 0.6% -32.8%
Return on Assets (ROA) -20.1% -28.9% -27.3% 25.7% 8.7% 2.5% 0.5% -30.4%
Current Ratio 18.14x 21.96x 22.62x 15.45x 29.86x 21.11x 19.29x 21.45x
Quick Ratio 17.62x 21.20x 21.93x 14.25x 28.93x 20.34x 18.74x 20.50x
Debt to Equity 0.05x 0.06x 0.06x 0.06x 0.02x 0.03x 0.03x 0.03x
Revenue Growth (YoY) +183.3% -100.0% -100.0% -- -- -- -- -100.0%
Operating Income Growth (YoY) -- -- -117.0% -- -- -- -- --
Net Income Growth (YoY) -- -- -116.0% -- -- -- -- --
EPS Growth (YoY) -- -- -133.1% -- -- -- -- --
Operating Cash Flow Growth (YoY) +4.3% -- -102.2% -- -- -- -- --
Free Cash Flow Growth (YoY) +6.9% -- -102.2% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001664710) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:45 UTC · Open in terminal